In men with classic hypogonadism, testosterone therapy induces a number of beneficial effects. However, in older men with age-related decline in testosterone levels, the clinical benefits and long-term risks of testosterone therapy have not been adequately assessed in large, randomized clinical trials. This Review discusses potential benefits and risks of testosterone therapy in these individuals in the context of incomplete evidence on safety and efficacy.
- Matthew Spitzer
- Grace Huang
- Shalender Bhasin